These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6352249

  • 1. Inhibition of insulin degradation by insulin-like growth factors.
    Misbin RI, Almira EC, Duckworth WC, Mehl TD.
    Endocrinology; 1983 Oct; 113(4):1525-7. PubMed ID: 6352249
    [Abstract] [Full Text] [Related]

  • 2. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
    Roth RA, Mesirow ML, Yokono K, Baba S.
    Endocr Res; 1984 Oct; 10(2):101-12. PubMed ID: 6389104
    [Abstract] [Full Text] [Related]

  • 3. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
    Hamel FG, Peavy DE, Ryan MP, Duckworth WC.
    Endocrinology; 1986 Jan; 118(1):328-33. PubMed ID: 3510119
    [Abstract] [Full Text] [Related]

  • 4. Interaction of insulin-like growth factor I with porcine thyroid cells cultured in monolayer.
    Saji M, Tsushima T, Isozaki O, Murakami H, Ohba Y, Sato K, Arai M, Mariko A, Shizume K.
    Endocrinology; 1987 Aug; 121(2):749-56. PubMed ID: 3036481
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor receptors in rat placental membranes.
    Pilistine SJ, Moses AC, Munro HN.
    Endocrinology; 1984 Sep; 115(3):1060-5. PubMed ID: 6086283
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor stimulates glycogen synthesis in fetal rat hepatocytes: comparison with the glycogenic effects of insulin-like growth factor I and insulin.
    Freemark M.
    Endocrinology; 1986 Aug; 119(2):522-6. PubMed ID: 3525120
    [Abstract] [Full Text] [Related]

  • 7. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
    Myal Y, Shiu RP, Bhaumick B, Bala M.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG, Hamel FG, Duckworth WC.
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [Abstract] [Full Text] [Related]

  • 9. Binding and degradation of insulin-like growth factors I and II by rat kidney membrane.
    Bhaumick B, Bala RM.
    Endocrinology; 1987 Apr; 120(4):1439-48. PubMed ID: 3549261
    [Abstract] [Full Text] [Related]

  • 10. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
    Yonezawa K, Yokono K, Yaso S, Hari J, Amano K, Kawase Y, Sakamoto T, Shii K, Imamura Y, Baba S.
    Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
    [Abstract] [Full Text] [Related]

  • 11. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI, Almira EC.
    Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
    [Abstract] [Full Text] [Related]

  • 12. Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells.
    Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY.
    Endocrinology; 1988 Apr; 122(4):1603-12. PubMed ID: 3278892
    [Abstract] [Full Text] [Related]

  • 13. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
    Williams FG, Johnson DE, Bauer GE.
    Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors.
    Kayalar C, Wong WT, Hendrickson L.
    J Cell Biochem; 1990 Nov; 44(3):137-51. PubMed ID: 2269683
    [Abstract] [Full Text] [Related]

  • 15. The processing of insulin-like growth factor-I (IGF-I) by a cultured kidney cell line is altered by IGF-binding protein-3.
    Fawcett J, Rabkin R.
    Endocrinology; 1995 Apr; 136(4):1340-7. PubMed ID: 7534695
    [Abstract] [Full Text] [Related]

  • 16. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture.
    Goodyer CG, De Stephano L, Guyda HJ, Posner BI.
    Endocrinology; 1984 Oct; 115(4):1568-76. PubMed ID: 6148234
    [Abstract] [Full Text] [Related]

  • 17. Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action.
    Davoren JB, Kasson BG, Li CH, Hsueh AJ.
    Endocrinology; 1986 Nov; 119(5):2155-62. PubMed ID: 2945713
    [Abstract] [Full Text] [Related]

  • 18. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG, Fawcett J, Tsui BT, Bennett RG, Duckworth WC.
    Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
    [Abstract] [Full Text] [Related]

  • 19. Trophic actions of human somatomedin C/insulin-like growth factor I on ovarian cells: in vitro studies with swine granulosa cells.
    Veldhuis JD, Furlanetto RW.
    Endocrinology; 1985 Apr; 116(4):1235-42. PubMed ID: 3882403
    [Abstract] [Full Text] [Related]

  • 20. Purification and characterization of insulin-degrading enzyme from pig skeletal muscle.
    Yokono K, Imamura Y, Shii K, Sakai H, Baba S.
    Endocrinology; 1981 Apr; 108(4):1527-32. PubMed ID: 7009152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.